Survey: Access to Treatments for the Management of Immune-Related Colitis
Last year an Immunotherapy Specialist Interest Group was established at BOPA, and we are delighted to invite you to take part in our first piece of work.
As a group, we are keen to address the known disparity across the UK with regards to access to drugs for immune-related adverse effects.
To begin with, we aim to gain further perspective of access to vedolizumab for immune-related colitis for which your involvement is vital. Please find below the link to take you to the survey, which should take between 5-10 minutes to complete. Analysis of these results will be used to drive some real-world data collection, therefore please do share your email address if you are keen to collaborate.
Please get in touch if you have any queries and thank you for your contribution.
Alice, Meera, Faye, Jo and Kavita
